Failure-to-Thrive in an Infant Following Injection of Capillary Hemangioma With Triamcinolone Acetonide

Abstract

Keywords

Get full access to this article

View all access options for this article.

References

Brook CG Side effects of steroids revisited. J Pediatr. 2000;137:3-4.

Daley-Yates PT , Richards DH Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/ pharmacodynamic model. Clin Ther. 2004;26:1905-1919.

Chen MT , Yeong EK , Horng SY Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases. J Pediatr Surg. 2000 ; 35:420-423.

Christison-Lagay ER , Fishman SJ Vascular anomalies. Surg Clin North Am. 2006;86:393-425, x.

Glatt HJ , Putterman AM , Van Aalst JJ , Levine MR Adrenal suppression and growth retardation after injection of periocular capillary hemangioma with corticosteroids. Ophthalmic Surg. 1991;22:95-97.

Kim HJ , Colombo M. , Frieden IJ Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol. 2001;44:962-972.

Kumar S. , Singh RJ , Reed AM , Lteif AN Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients. Pediatrics . 2004;113:1820-1824.

Kalina PH , Erie JC , Rosenbaum L. Biochemical quantification of triamcinolone in subconjunctival depots. Arch Ophthalmol. 1995;113:867-869.

Derendorf H. , Hochhaus G. , Rohatagi S. , et al. Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration. J Clin Pharmacol. 1995;35:302-305.

10.

Katzung B , ed. Basic and Clinical Pharmacology. 10th ed. New York, NY: McGraw-Hill; 2007.